| Product NDC: | 0187-2200 | 
| Proprietary Name: | CeraVe | 
| Non Proprietary Name: | Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide | 
| Active Ingredient(s): | 4.95; 4.95; 4.95; 2.48; 23.41 g/99g; g/99g; g/99g; g/99g; g/99g & nbsp; Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide | 
| Administration Route(s): | TOPICAL | 
| Dosage Form(s): | LOTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0187-2200 | 
| Labeler Name: | Valeant Pharmaceuticals North America LLC | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | part352 | 
| Marketing Category: | OTC MONOGRAPH FINAL | 
| Start Marketing Date: | 20120827 | 
| Package NDC: | 0187-2200-01 | 
| Package Description: | 99 g in 1 TUBE (0187-2200-01) | 
| NDC Code | 0187-2200-01 | 
| Proprietary Name | CeraVe | 
| Package Description | 99 g in 1 TUBE (0187-2200-01) | 
| Product NDC | 0187-2200 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide | 
| Dosage Form Name | LOTION | 
| Route Name | TOPICAL | 
| Start Marketing Date | 20120827 | 
| Marketing Category Name | OTC MONOGRAPH FINAL | 
| Labeler Name | Valeant Pharmaceuticals North America LLC | 
| Substance Name | HOMOSALATE; MERADIMATE; OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE | 
| Strength Number | 4.95; 4.95; 4.95; 2.48; 23.41 | 
| Strength Unit | g/99g; g/99g; g/99g; g/99g; g/99g | 
| Pharmaceutical Classes |